Dr. Sergio E. Rojter, MD

Dr. Rojter practices at Sergio E Rojter MD a Professional Corporation in Los Angeles, California.

Dr. Rojter's NPI, 1891716494, was assigned on July 21, 2006. Dr. Rojter graduated from University of Buenos Aires in 1985. Dr. Rojter holds California license A63254.

Dr. Rojter's primary practice is Sergio E Rojter MD a Professional Corporation, at 1245 W Wilshire Blvd, Los Angeles, CA 90017 in Los Angeles County. The practice phone is (213) 250-3344.

Dr. Rojter's primary practice is Sergio E Rojter MD a Professional Corporation in Los Angeles, California. Dr. Rojter is also affiliated with Adventist Health White Memorial. The medical group on file is Sergio E Rojter MD A Professional Corporation. Dmand AI also links Dr. Rojter to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rojter practices, 2 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Rojter's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Rojter is licensed in California.

Dmand AI lists cirrhosis of the liver, fatty liver and hepatitis c among the conditions Dr. Rojter treats.

CMS data shows 508 Medicare services from Dr. Rojter across 5 procedure codes in 2024, for 302 Medicare patients. Medicare paid $41,336 for them. Every service was in an office.

CMS counts 302 Medicare patients who saw Dr. Rojter in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 93% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rojter's median patient age at 58, with 59% women.

In 2024, Dr. Rojter wrote 601 Medicare Part D claims for 95 patients. 77% of them were for generic drugs. CMS names the drug for 548 of them, across 12 drugs with 11 or more claims each, at $614,417 in total drug cost. In 2023, CMS named 439 claims across 12 drugs.

CMS lists Dr. Rojter as offering telehealth.

Dmand AI links 2 papers to Dr. Rojter, published from 2015 to 2019. Dr. Rojter's most frequent co-authors are Kyle P. Etzkorn, MD, Bradley Lawrence Freilich, MD and Norman Gitlin, MD.

Dmand AI links Dr. Rojter to 1 clinical trial. Conditions studied include Hepatitis D and Hepatitis, Viral, Human.

CMS Open Payments shows 352 general payments to Dr. Rojter from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Gilead Sciences, Inc. paid the most, $85,549. It also lists 1 research payment totaling $78 in 2019.

Dr. Rojter graduated from University of Buenos Aires in 1985. Dr. Rojter is a member of American Association for the Study of Liver Diseases and European Association for the Study of Liver Diseases.

Dr. Rojter is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.